By Mill Chart
Last update: Sep 19, 2024
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Ticker | Change | Comment |
---|---|---|
BNZI | 4.0K% | BANZAI INTERNATIONAL INC (NASDAQ:BNZI) witnessed a notable 4.0K% uptick in its shares, reaching $2.58 during Thursday's session. In the last month the stock lost 40.27%. |
GDHG | 3.0K% | GOLDEN HEAVEN GROUP HOLDINGS's (NASDAQ:GDHG) shares rose 3.0K% to $2.59. The stock is trading 31.41% lower than a month ago. |
SGN | 414.0% | SIGNING DAY SPORTS INC's (NYSEARCA:SGN) stock price increased by 414.0% to $0.67. A press release (Signing Day Sports Signs Binding Term Sheet to Acquire Majority Equity Interest in High Growth Sports Gaming Technology Company Swifty Global) was released earlier today. |
GSIW | 150.0% | Positive market sentiment drove GARDEN STAGE LTD's (NASDAQ:GSIW) stock price up by 150.0% to $5.67 during Thursday's session. In the last month the stock lost 68.3%. |
TBIO | 102.0% | With a 102.0% surge, TELESIS BIO INC's (NASDAQ:TBIO) stock price reached $2.74 during Thursday's session, signaling positive momentum. In the last month the share price dropped with 60.58%. |
XCUR | 65.07% | EXICURE INC (NASDAQ:XCUR) witnessed a notable 65.07% uptick in its shares, reaching $3.78 during Thursday's session. The stock is trading 22.46% higher than a month ago. |
EWTX | 51.65% | Positive market sentiment drove EDGEWISE THERAPEUTICS INC's (NASDAQ:EWTX) stock price up by 51.65% to $28.92 during Thursday's session. Earlier today the company had a press release: Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM). |
GLMD | 43.33% | GALMED PHARMACEUTICALS LTD's (NASDAQ:GLMD) shares rose 43.33% to $9.89. Two days ago the company had a press release: Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?. |
RYDE | 36.28% | Investors celebrated as RYDE GROUP LTD-A (NYSEARCA:RYDE) experienced a 36.28% rise in its shares, closing at $1.54 during Thursday's session. In the last month the stock lost 88.53%. |
VERO | 28.4% | Exciting news for VENUS CONCEPT INC (NASDAQ:VERO) as its stock price surged 28.4% to $0.65 during Thursday's session. Shareholders saw the stock price going 39.66% lower in the past 3 months. |
For the full top gainers list go to our top gainers page.